Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Doctors need to be better prepared to assess and treat obesity in patients.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Early detection and treatment of PCOS in teenagers is important to manage symptoms and prevent severe issues.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Iraqi women with PCOS often have higher testosterone levels and obesity.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.